Privia Health Group, Inc.PRVANASDAQ

|||

Overview Charts News Fundamentals Key Metrics TTM Financials Earnings Growth Rating Analysts Institutional Peers Historical

Analyst Sentiment

Analysts lean bullish — 90% recommend buying.

Consensus Rating

Buy

21 analysts·High coverage

90%

Rating Distribution

Strong Buy

00%

Buy

1990%

Hold

210%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see moderate upside — consensus target 29% higher.

Bear Case

$22.00

-4%

Consensus

$29.60

+29%

Bull Case

$34.00

+48%

Price Range21 analysts

Low

Consensus

High

$22.00

$34.00

Current Target

Current Price

$22.91

Upside to Target

$6.69

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$0.32(10 analysts)

P/E155x

Current: 154.9x

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+11.18%

EPS+34.01%

FY2028

Rev+16.59%

EPS+42.97%

FY2029

Rev+11.22%

EPS+28.10%

Earnings Surprises

Beat rate:17%(2/12 quarters)

Avg surprise:+39.6%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Jan 9, 2026RBC Capital

Privia Health resumed with an Outperform at RBC Capital

Target:$31.00

+33.9%from $23.15

Jan 6, 2026Wolfe Research

Privia Health Group (PRVA) Reiterated at Market Outperform by Citizens

Target:$31.00

+28.4%from $24.14

Nov 12, 2025Canaccord Genuity

Privia Health price target raised to $34 from $32 at Canaccord

Target:$34.00

+39.8%from $24.32

Oct 9, 2025Barclays

Privia Health price target raised to $22 from $21 at Barclays

Target:$22.00

-10.3%from $24.53

Aug 29, 2025JMP Securities

Privia Health price target raised to $30 from $29 at Citizens JMP

Target:$30.00

+37.6%from $21.81

Apr 15, 2025Robert W. Baird

Privia Health price target raised to $26 from $24 at Baird

Target:$26.00

+7.9%from $24.10

Feb 28, 2025JMP Securities

Privia Health price target raised to $29 from $26 at Citizens JMP

Target:$29.00

+16.1%from $24.97

Feb 28, 2025Piper Sandler

Privia Health price target raised to $40 from $25 at Piper Sandler

Target:$40.00

+60.2%from $24.97

Feb 28, 2025Canaccord Genuity

Privia Health price target raised to $30 from $29 at Canaccord

Target:$30.00

+20.1%from $24.97

Jan 10, 2025Needham

Privia Health initiated with a Buy at Needham

Target:$25.00

+21.9%from $20.51

Aug 26, 2024Robert W. Baird

Privia Health Group Inc (PRVA) PT Raised to $24 at Baird

Target:$24.00

+14.1%from $21.03

Aug 8, 2024Evercore ISI

Privia Health Group Inc (PRVA) PT Raised to $22 at Evercore ISI

Target:$22.00

+13.7%from $19.35

May 20, 2024Barclays

Privia Health price target lowered to $19 from $22 at Barclays

Target:$19.00

+12.4%from $16.90

May 15, 2024Truist Financial

Privia Health Group Inc (PRVA) PT Lowered to $24 at Truist Securities

Target:$24.00

+33.0%from $18.05

Dec 8, 2022UBS

UBS Initiates Coverage On Privia Health Group with Buy Rating, Announces Price Target of $30

Target:$30.00

+28.7%from $23.31

Nov 17, 2022Canaccord Genuity

Privia Health (PRVA) Stock Receives $43 Price Target

Target:$43.00

+78.9%from $24.04

Nov 11, 2022Leerink Partners

SVB Leerink Maintains Outperform on Privia Health Group, Lowers Price Target to $39

Target:$39.00

+36.7%from $28.53

Aug 25, 2022Canaccord Genuity

Canaccord Genuity Maintains Buy on Privia Health Group, Raises Price Target to $50

Target:$50.00

+17.7%from $42.49

Aug 12, 2022Truist Financial

Truist Securities Maintains Buy on Privia Health Group, Raises Price Target to $48

Target:$48.00

+24.9%from $38.43

Aug 12, 2022Credit Suisse

Credit Suisse Maintains Outperform on Privia Health Group, Raises Price Target to $41

Target:$41.00

+6.4%from $38.55

Aug 12, 2022Cowen & Co.

Cowen & Co. Maintains Outperform on Privia Health Group, Raises Price Target to $44

Target:$44.00

+14.5%from $38.43

Aug 12, 2022Guggenheim

Privia Health price target raised to $51 from $36 at Guggenheim

Target:$51.00

+34.7%from $37.87

Aug 12, 2022Leerink Partners

SVB Leerink Maintains Outperform on Privia Health Group, Raises Price Target to $46

Target:$46.00

+21.5%from $37.87

Jul 25, 2022Truist Financial

Privia Health (PRVA) Stock: $40 Target And Buy Rating

Target:$40.00

+9.9%from $36.41

May 13, 2022Canaccord Genuity

Canaccord Genuity Maintains Buy on Privia Health Group, Lowers Price Target to $29

Target:$29.00

+20.6%from $24.05

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance